Breast Imaging Market: Global Industry Analysis and Forecast (2021-2029)

Breast Imaging Market was valued at US$ 4.1 Bn. in 2021 The global Breast Imaging Market size is expected to grow at a CAGR of 7.8 % through the forecast period.
Breast Imaging Market Overview:
Breast imaging techniques are used to diagnose breast-related abnormalities such as fibroadenoma, fibroadenoma, ductal obstruction, intraductal papilloma, and cysts. These breast imaging techniques are used by doctors and tumor surgeons to diagnose breast structure, cell composition, lumps, and other internal parts of the breast. Breast imaging plays an important role in detecting cancer cells and lumps before they are felt with bare hands, leading to lower breast disease mortality around the world. Increased prevalence and incidence of breast cancer, increased awareness of early detection of breast cancer and other related diseases, innovation and introduction of advanced breast imaging equipment and software, investment in breast cancer treatment and aging research and development Increasing Funds The female population is driving the growth of the breast imaging market and the opportunities for the breast imaging market.



To know about the Research Methodology:-Request Free Sample Report

2021 is considered as a base year to forecast the market from 2022 to 2029. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. The past five years' trends are considered while forecasting the market through 2029. 2021 is a year of exception and analysis, especially with the impact of lockdown by region.

Breast Imaging Market Covid-19 Impact: The COVID-19 pandemic has had a negative impact on various markets around the world. It also had a significant impact on the breast imaging market. Lockdowns and other restrictions imposed by governments around the world have hampered market demand. In addition, governments have introduced restrictions to suspend elective and non-urgent medical treatments to slow the spread of the virus. In addition, fears of contracting the virus led to a sharp decline in breast imaging, particularly during the first COVID-19 wave in 2020. In Turkey compared to 2019 data, there was a 64% decrease in mammography, a 47.7% increase in breast ultrasound, and a decrease in MRI cases with Breast Imaging up 41.7% Thus, COVID-19 had severely impacted the breast imaging market. In addition, the continued increase in COVID-19 cases in major breast imaging markets such as North America and Europe completely impedes individual mobility and delays regular breast examinations associated with cancer detection.
Breast Imaging Market Dynamics:
Breast Imaging Market Drivers:

Growth in the international breast imaging technology sector is driven primarily by the increased prevalence of breast cancer, increased demand for early detection, increased funding from private and government agencies for the development of medical infrastructure, and an increase in the female population. It has been. In 2021, approximately 281,550 new cases of invasive breast cancer were diagnosed in women in the United States. In addition, one in eight women in the United States will develop invasive breast cancer in their lifetime. In addition, increasing approval of breast imaging technology is driving the growth of the breast imaging technology market. For example, in April 2021, the US Food and Drug Administration (FDA) approved Seno Medical's Imagio P200003 breast imaging system for use in breast tissue imaging.

In addition, the presence of leading manufacturers of advanced breast imaging technology devices is contributing to the growth of the market. For example, in October 2021, medical imaging company Delphinus Medical Technologies announced pre-approval by the US FDA for the SoftVue 3D whole-breast ultrasound imaging system. It is used to prevent breast cancer.

Moreover, the increasing prevalence of women over the age of 45, who are prone to breast cancer, is driving the market growth. According to the American Cancer Society, it has been observed that about half of women population over the age of 62 are diagnosed with breast cancer.

In addition, technological developments in the medical equipment sector to manufacture advanced breast imaging technology are expected to provide an opportunity for the breast imaging technology market to expand during the forecast period. In addition, the increasing number of screening techniques and the increasing demand for early detection are driving the market growth.

Government and private organization initiatives to develop the medical device market are driving the growth of the breast imaging technology market. However, the high cost of breast cancer detection and the rigorous regulatory approval process limits market growth during the forecast period of the breast imaging technology market.

Breast Imaging Market Restraints:

Breast imaging is essential for the early detection of breast cancer. However, some breast imaging methods use ionizing radiation for diagnosis. Ionizing radiation includes digital mammography (DM) and digital breast tomosynthesis (DBT), as well as contrast-enhanced mammography (CEM), total breast CT (WBCT), and breast-specific gamma imaging (BSGI). ), Molecular Breast Imaging (MBI), and Positron Emission Mammography (PEM). Therefore, the increased risk of radiation exposure will continue to challenge the mammography market.

On the other hand, the high costs associated with imaging systems and technologies will hinder the market growth. Unfavorable redemption scenarios in developing and underdeveloped economies also pose significant challenges to the breast imaging market. However, strict regulatory approval procedures and the development of adverse conditions due to the occurrence of COVID-19 will limit and further impede market growth during the 2022-2029 forecast period.

Breast Imaging Market Opportunities:

Recent advances in imaging technology have revolutionized the aspects of treatment and its access. The combination of imaging techniques such as CT scan, MRI, and PET is becoming increasingly important for visualizing metabolic information and anatomical details of organs. In addition, these integrated diagnostic imaging methods improved breast image quality and patient comfort, and reduced patient dose. Because of these benefits, manufacturers around the world are further focusing on introducing new products to increase the sensitivity and accuracy of a breast cancer diagnosis.
Breast Imaging Market Segment Analysis:
Based on the Technology: the Breast Imaging Market is segmented into Ionised, non-ionized breast imaging technology, and others. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the prediction interval. The growth of this segment may be due to the following non-ionized breast imaging techniques being superior to ionized breast imaging techniques: B. More anatomical details for diagnosis, more sensitivity to small breast lesions in women with dense breast tissue, and fewer false positives.

Based on End-user: the Breast Imaging Market is segmented into hospitals, ambulatory centers, diagnostic centers, and cancer care centers. Hospitals and clinics are expected to gain the largest market share in the breast imaging market. The main factors that maintain the advantage of hospitals and clinics are increased investment in medical infrastructure development, increased purchasing power, availability of well-equipped operating and diagnostic rooms, and hospital-based medical services. Includes improved healthcare delivery. Increased investment in healthcare infrastructure development, increased purchasing power, availability of well-equipped operating and diagnostic rooms, and better healthcare delivery for hospital-based healthcare services are key factors driving hospital dominance.


Breast Imaging Market Regional Insights:
The North America region dominated the market with 35 % share in 2021, followed by Europe, Asia Pacific, Latin America, the Middle East and Africa. However, the Asia-Pacific region is the fastest-growing regional market due to the accelerating economic growth of many countries in the region. Increasing prevalence of breast cancer; the government is increasingly focusing on improving the healthcare sector. In addition, frequent breast screening programs to raise awareness of the importance of early detection in the region are another key driver of growth in the Asia-Pacific breast imaging market.

The objective of the report is to present a comprehensive analysis of the global Breast Imaging Market to the stakeholders in the market. The past and current status of the market with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the market with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Breast Imaging Market dynamic, structure by analyzing the market segments and projecting the Breast Imaging Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Breast Imaging Market make the report investor’s guide.
Breast Imaging Market Scope: Inquire before buying



Global Breast Imaging Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US$ 4.1 Bn.


Forecast Period 2022 to 2029 CAGR:
7.8%
Market Size in 2029:
US$ 8.06 Bn.


 Segments Covered:
by Technology
• Ionic technology
• Non-Ionic Technology
• Other


by End User
• Hospitals
• Ambulatory Centers
• Cancer Care Centers
• Diagnostic centers



Breast Imaging Market by Region
• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa
Breast Imaging Market Key Players
• Hologic Inc
• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips N.V
• Fujifilm holdings corp.
• Canon Inc
• Aurora Healthcare
• Allengers
• Dilon tech Inc
• Planmed Oy
• Delphinus Medical Tech
• Micrima Ltd
• CMR Naviscan Corp
• SuperSonic Imagine
• Carestream Health

Frequently Asked Questions:

1] What segments are covered in the Global Breast Imaging Market report?
Ans. The segments covered in the Breast Imaging Market report are based on Technology and End User.

2] Which region is expected to hold the highest share in the Global Breast Imaging Market?
Ans. The North America region is expected to hold the highest share in the Breast Imaging Market.

3] What is the market size of the Global Breast Imaging Market by 2029?
Ans. The market size of the Breast Imaging Market by 2029 is expected to reach US$ 8.06 Bn.

4] What is the forecast period for the Global Breast Imaging Market?
Ans. The forecast period for the Breast Imaging Market is 2022-2029.

5] What was the market size of the Global Breast Imaging Market in 2021?
Ans. The market size of the Breast Imaging Market in 2021 was valued at US$ 4.1 Bn.